XTLBNasdaqPharmaceutical Preparations

XTL BIOPHARMACEUTICALS LTD

Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Jun 30, 2026

$1.96−0.00 (-0.01%)

Close on Oct 19, 2026

Community

Notes and questions about Xtl Biopharmaceuticals from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Xtl Biopharmaceuticals's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-4 reverse split on Mar 25, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is XTLB.

Advertisement
300 × 250